AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with ...

ARLINGTON, Va.--(BUSINESS WIRE)--AvalonBay Communities, Inc. (NYSE: AVB) (the “Company”) announced today that its Board of Directors declared a cash dividend on the Company’s Common Stock (par value ...

Real-time index price for Nasdaq Global Select Market Composite Index (NQGS), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

With the Federal Reserve potentially cutting interest rates for the first time in over four years, uncertainty looms in the ...

Even more alarming is AbbVie's payout ratio of 216.7%, far surpassing the peer average of 141%. This sky-high figure means ...

The conventional wisdom is that there are two important aspects of timing in investing: when to buy a stock and when to sell ...

Overall, ABBV has an impressive portfolio of products and more ... Data by YCharts And like the other holdings we have seen, the dividend growth history is solid. You can expect annual dividend hikes ...

As of 12 September at 15:15 GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

A diversified portfolio balances the need for growth along with the need for stability. After all, small-cap biotech stocks and software startups may deliver a big payday if all goes ...

This announcement marks another step in AbbVie's history of providing dividends to its shareholders. Since its formation in 2013, the pharmaceutical company has increased its dividend payout by more ...